Generics 25

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Salmeterol manufacturers

25 products found

Filters

25 products found

salmeterol + fluticasone

Inhalation powder 50mcg+100mcg, 50mcg+250mcg, 50mcg+500mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

salmeterol + fluticasone propionate

Inhalation gas 25mcg+125mcg, 25mcg+250mcg, 25mcg+500mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

salmeterol

Inhalation powder 50 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #11542
It is one of the most rapidly expanding pharmaceutical enterprises in Europe. A cutting-edge pharmaceutical manufacturing plant and a laboratory with the highest-quality equipment are among the manufacturing facilities. The production lines and laboratories follow European standards, and a team of competent personnel ensures that these guidelines are followed. The manufacturing procedures meet all GMP regulations, whereas clinical trial goods are made per GLP and GMP principles.

Manufacturer usually replies in 9 days

salmeterol

Inhaler 25 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #15932

A pharmaceutical manufacturer based in the EU that is active in 20+ countries for 20+ years. Key production lines are generic, medical device, OTC, nutraceuticals, and cosmetics. They are produced in GMP-compliant manufacture. Main therapeutic areas include allergology and pulmonology, cardiology, dermatology, and the central nervous system. The main dosage forms are liquid, solid, semi-solid, and sprays.

Manufacturer usually replies in 11 days

salmeterol + fluticasone

Inhaler 25 mcg + 50 mcg, 25 mcg + 125 mcg, 25 mcg + 250 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
Metered-dose inhaler (MDI)
Manufacturer #6580
A pharmaceutical manufacturer based in the EU that has been active in 20+ countries selling its products in Europe, MENA, LATAM, Asia, and NA for 20+ years. Key production lines are Rx and medical devices. Main therapeutic areas include oncology and respiratory. The company's production lines are GMP-compliant.

Manufacturer usually replies in 11 days

salmeterol + fluticasone

Inhalation powder 50 mcg + 250 mcg , 50 mcg + 500 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29017

Manufacturer usually replies in nan days

salmeterol + fluticasone

Inhalation powder 50mcg + 100 mcg, 50mcg + 250 mcg, 50+ 500 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #15227
It is a pharmaceutical company founded in 2000 in southeast Europe. The research and production of high-tech inhalers and biotechnology goods is the key focus. The firm specializes in difficult-to-make items and attempts to create high-quality items. It is one of the first companies in a country that started developing biosimilars for international markets, including the United States and the European Union.

Manufacturer usually replies in 2 days

salmeterol + fluticasone

Pressurised inhalation 25mcg + 125mcg, 25mcg + 250mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Unavailable markets
Peru
Manufacturer #16220
It is a pharmaceutical company that has been in business for more than 28 years. They are continually investing in cutting-edge technology, allowing us to remain extremely competitive and ensure world-class quality in all of our products. The company's product portfolio includes a diverse range of pharmaceutical forms and therapeutic lines.

Manufacturer usually replies in 6 days

salmeterol + fluticasone

Inhalation gas 25mcg + 125mcg, 25mcg + 250mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Unavailable markets
Peru
Manufacturer #16220
It is a pharmaceutical company that has been in business for more than 28 years. They are continually investing in cutting-edge technology, allowing us to remain extremely competitive and ensure world-class quality in all of our products. The company's product portfolio includes a diverse range of pharmaceutical forms and therapeutic lines.

Manufacturer usually replies in 6 days

salmeterol + fluticasone

Inhaler 25 mcg + 125 mcg, 25 mcg + 250 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #21118

Manufacturer usually replies in 12 days

salmeterol + fluticasone propionate

Inhalation powder 50 mcg + 100 mcg, 50 mcg + 250 mcg, 50 mg + 500 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18447

Manufacturer usually replies in 11 days

salmeterol + fluticasone propionate

Inhalation powder 50 mcg + 250 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, Cambodia, Ethiopia, Kenya, Tanzania, Yemen
Registered in
India , Tanzania , Yemen , Kenya , Ethiopia , Cambodia
Available for
Licensing with supply
Manufacturer #20282

Manufacturer usually replies in 23 days

salmeterol + fluticasone

Inhaler 25 mcg + 125 mcg, 25 mcg + 250 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
FDA, EU GMP
Manufacturer #32131

Manufacturer usually replies in nan days

salmeterol + fluticasone

Inhalation powder 50 mcg + 100 mcg, 50 mcg + 250 mcg, 50 mcg + 500 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
FDA, EU GMP
Comments
Available as Airmaster (50 mcg + 100 mcg, 50 mcg + 250 mcg, 50 mcg + 500 mcg) and Capsair (50 mcg + 250 mcg, 50 mcg + 500 mcg)
Manufacturer #32131

Manufacturer usually replies in nan days

budesonide + salmeterol

Inhalation powder 120 µg + 20 µg, 240 µg + 20 µg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iran
Registered in
Bulgaria , Romania
Manufacturer #653

Manufacturer usually replies in nan days

fluticasone propionate + salmeterol

Inhalation powder 500 mcg + 50 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17633
In the 1950s, the pharmaceutical laboratory was established. Its first manufacturing facility for inhalation aerosols was established in the 1960s, making it one of the first companies to introduce such a product to the market. It was one of the first firms in the world to sell silver sulfadiazine as a pharmaceutical product in cream and aerosol form.

Manufacturer usually replies in 9 days

fluticasone + salmeterol

Pressurised inhalation 100+50mcg, 250+50mcg, 500+50mcg/dose

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #623

Manufacturer usually replies in 9 days

fluticasone + salmeterol

Inhalation powder 125/25; 250/25

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #11542
It is one of the most rapidly expanding pharmaceutical enterprises in Europe. A cutting-edge pharmaceutical manufacturing plant and a laboratory with the highest-quality equipment are among the manufacturing facilities. The production lines and laboratories follow European standards, and a team of competent personnel ensures that these guidelines are followed. The manufacturing procedures meet all GMP regulations, whereas clinical trial goods are made per GLP and GMP principles.

Manufacturer usually replies in 9 days

fluticasone + salmeterol

Inhalation powder 500 mcg + 50 mcg, 250 mcg + 50 mcg, 100 mcg + 50 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Seretide Diskus®
Manufacturer #252

Manufacturer usually replies in 2 days

fluticasone propionate + salmeterol

Inhaler 100 µg + 50 µg, 250 µg + 50 µg, 500 µg + 50 µg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
EU GMP, COFEPRIS, INVIMA
Manufacturer #18696
The company has an experience of more than 80 years of medicine. It is one of the leading companies in a wide range of quality pharmaceuticals for both the prescription medication and the OTC market. They are committed to excellence, high quality, and social standards and pledge to offer quality products at accessible prices, which constitute the basis of our success.

Manufacturer usually replies in 7 days

Want to view all 25 products? Create your free account today!

Salmeterol Manufacturers and Suppliers

Salmeterol is a long-acting beta-2 adrenergic receptor agonist used to treat asthma and COPD, available under the brand name “Serevent”. It is indicated for the treatment of chronic obstructive pulmonary disease symptoms such as wheezing, shortness of breath, coughing, and chest tightness. It is also used to prevent bronchospasm (breathing difficulties) during exercise in adults and children aged 4 and up. It is a dry powder that is inhaled by mouth with a specially developed inhaler. It is commonly taken twice a day, in the morning and evening, about 12 hours apart, to treat asthma or COPD. This pharmaceutical medicine is often administered at least 30 minutes before exercise and no more than once per 12 hours to prevent breathing issues during exercise. Palpitations, rapid heart rate, high blood pressure, tremor, nervousness, and headache are some of the side effects associated with this pharmaceutical medicine. It is possible to experience throat and upper airway inflammation. This drug may increase the risk of asthma-related death. As a result, it should be used only in patients whose asthma has not been managed by previous medicines and who are on another long-term asthma-controlling medication. While not strictly contraindicated, this drug should be used with caution in patients who have an existing cardiovascular disorder, convulsive disorder, hepatic impairment, diabetes mellitus, hyperthyroidism/thyrotoxicosis, or who use other CYP3A inhibitors, as this may increase toxicity and prolong the patient's QT interval. During pregnancy, inhalation of this drug should be used only if the possible benefit outweighs the potential harm to the fetus. When administering it to nursing mothers, extreme caution should be maintained.

How does Salmeterol work?

This drug activates beta-2 receptors in the bronchial musculature resulting in their relaxation and thus prevents the start and severity of asthma symptoms.

The Wholesale Price of Salmeterol

Salmeterol inhalation powder (100 mcg-50 mcg) costs about $153 for a supply of 60 powders. The prices may vary in different drugstores.

Navigating our pharmaceutical marketplace

Pipelinepharma is a global B2B online marketplace that is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The Salmeterol list can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturers and this substance suppliers . Each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Salmeterol is already registered in. Manufacturers may also have special delivery terms.

Establishing commercial ties

After completing the free registration process and joining Pipelinepharma online marketplace, you can enter into deals or talks with manufacturing companies about this drug offer, if you are a pharmaceutical licensing company or a distributor. This ensures that you close the pharmaceutical deal at a reasonable cost while avoiding the time-consuming sourcing, negotiating, and ordering procedure. Pipelinepharma allows you to bypass the process of shortlisting product makers as a distributor.

Quality assurance

All pharmaceutical companies are qualified before they are onboarded on Pipelinepharma’s online platform to ensure that they meet the quality requirements. This enables the site to assess Salmeterol manufacturers for the quality of pharmaceutical product dossiers and defend against the risk of potential malpractices.